The use of Low Molecular Weight Heparin to Predict Clinical Outcome in Patients with Unstable Angina That Had Undergone Percutaneous Coronary Intervention

BACKGROUND: Antithrombotic therapy with heparin reduces the rate of ischemic events in patients with acute coronary syndrome. Low-molecular-weight heparin, given subcutaneously twice daily, has a more predictable anticoagulant effect than standard unfractionated heparin. Moreover, it is easier to ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Young Joon, Jeong, Myung Ho, Lee, Seung Hyun, Park, Ok Young, Kim, Ju Han, Kim, Weon, Rhew, Jay Young, Ahn, Young Keun, Cho, Jeong Gwan, Park, Jong Chun, Suh, Soon Pal, Ahn, Byoung Hee, Kim, Sang Hyung, Kang, Jung Chaee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2003
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531631/
https://www.ncbi.nlm.nih.gov/pubmed/14619386
http://dx.doi.org/10.3904/kjim.2003.18.3.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531631/
https://www.ncbi.nlm.nih.gov/pubmed/14619386
http://dx.doi.org/10.3904/kjim.2003.18.3.167

Ejemplares similares